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Abstract To characterize the clinical manifestations of patients
with systemic sclerosis who develop a myocardial infarction (MI), a
retrospective review of the medical records of all patients who were
admitted to our institution between 1982 and 2002 and had the
dual diagnosis of systemic sclerosis and an acute MI was done.
From 1,009 systemic sclerosis hospital admissions, 11 (1.09%)
were for an acute MI. Three of these patients had normal
coronaries, and instead of wall motion abnormalities, left ventricular
hypertrophy was the predominant finding of an echocardiography.
The odds ratio of finding normal coronaries in systemic sclerosis vs
the general population who develops an acute MI is 33.89 (14.08–
81.39). Seven of our patients had an elevated creatinine level on
presentation. Acute MI is an uncommon manifestation in systemic
sclerosis patients. Normal coronaries are seen more commonly in
these patients as compared to the general population, while
vascular, gastrointestinal, and renal involvement is prevalent in
these patients.
.
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Introduction
Endothelial cell dysfunction is one of the fundamental abnormalities
in the pathogenesis of systemic sclerosis causing a progressive
vasculopathy most commonly involving the microvasculature
system. Less frequently, the vasculopathy of systemic sclerosis
may affect larger vessels. The most common clinical manifestation
of systemic sclerosis vasculopathy is Raynaud’s phenomenon, and
involvement of the kidneys, lungs, and the heart has been
extensively described. The vessels most commonly involved are

small arterioles (500–50 µ in diameter) and capillaries. Only rarely
has involvement of larger vessels been described [1, 2].
Cardiac involvement in systemic sclerosis is not uncommon,
occurring in approximately 20–25% of patients [3–5]. The most
prevalent clinical manifestations are angina, conduction defects,
myocardiopathies related to myocardial fibrosis, and arrhythmias. A
coronary artery vasospastic phenomenon (“Raynaud’s
phenomenon”) has also been described, and it has been
suggested that this alteration may cause myocardial ischemia with
angina symptoms as well as reperfusion injuries, leading to the
development of myocardial fibrosis [6].
The aim of this study was to characterize the clinical
manifestations of patients with systemic sclerosis who were
hospitalized at our institution for an acute myocardial infarction (MI)
between the years 1982 and 2002 and to identify a subgroup of
patients from this cohort who did not exhibit coronary vessel
atherosclerosis by cardiac catheterization or postmortem studies.
The clinical characteristics of this subgroup of patients were
examined in detail and were compared to historical control cases of
non-atherosclerotic MIs in the general population.
The prevalence rate of MI with normal to near-normal coronary
arteries in the general population varies between 1 and 12%
depending on the definition of “normal coronary vessels” [7–10].
This pattern is more commonly seen in younger individuals. In
patients below 30 years of age, it accounts for 16–35% of MIs [11].
The etiology of this syndrome is not clearly defined at this time,
although endothelial dysfunction, coronary microembolism, coronary vasospasm, an imbalance in oxygen supply and demand, and
nonatherosclerotic coronary artery disease have been postulated
as likely mechanisms.
Patients and methods
The inpatient medical record database of our institution, which is a
tertiary, university-based referral center, with a scleroderma clinic
that draws patients predominantly from the northeast part of the
USA, was searched using the diagnostic codes for systemic
sclerosis and acute MI. Cases were located among admissions
between 1982 (when the computerized database was first
established at our institution) and 2002. Twelve patients who

carried the dual diagnosis of systemic sclerosis and acute MI were
identified based on the diagnostic codes used, which included
coding changes implemented through the years of ascertainment.
The study was approved by the Institutional Review Board. A
thorough evaluation of the medical records allowed us to confirm
the diagnosis of systemic sclerosis in all except one of the patients
identified. All patients had a clearly defined history of MI which was
based on electrocardiographic changes and at least a twofold
increase in myocardial creatine kinase activity on presentation. The
demographic data of each patient being admitted to the hospital for
a MI were collected. The presence and severity of systemic
sclerosis visceral organ involvement were assessed employing a
previously described systemic sclerosis severity scale [12]. In this
scale, involvement of nine specific organs is rated from 0 (no
documented involvement) to 4 (end-stage disease).
Statistical analyses Quantitative data are presented as a mean with
a standard deviation, while qualitative data are presented as a
percentage of the total or as a ratio. The patients for whom clinical,
radiologic, or pathologic reports were not adequate to delineate
whether they had atherosclerotic cardiovascular disease were
assumed to have atherosclerosis to obtain the most conservative
estimate of nonatherosclerotic disease in the cohort studied.
Employing historical controls from a similarly designed
retrospective cohort study which examined MI admissions in the
general population with angiographically normal coronary arteries,
we calculated the odds ratio of having angiographically normal
coronary arteries in systemic sclerosis patients who had a recent
MI as compared to the general population, and a 95% confidence
interval is given [4].
Results
From 1,009 systemic sclerosis hospital admissions to our institution
between 1982 and 2002, 11 (1.09%) were for an acute MI. The
average age of this group of patients was 64.4±7.9 years old. Six
patients were women (54.5%), nine were white (81.8%), and two
were African-American (18.2%). Seven patients had limited
cutaneous systemic sclerosis (LcSSc) (63.6%), and four patients
had diffuse cutaneous systemic sclerosis (DcSSc) (36.4%).
Prevalent clinical symptoms related to systemic sclerosis were gastrointestinal (91%), peripheral vascular (81.8%) (seven out of nine
with severe Raynaud’s phenomenon), and renal (36.4%). The

extent of skin involvement based on total body surface clinically
affected by the sclerotic process was 15.1±12.3% (Table 1).
Modified Rodnan skin scores were not performed during the
inpatient hospitalization. Seven out of nine patients had positive
antinuclear anti-bodies. None of eight patients tested for
anticardiolipin antibodies were positive, and only one of eight
tested for lupus anticoagulant was positive. On presentation, 8 of
11 patients had substernal chest pain, and 3 of 11 had orthopnea
and dyspnea. Mean initial creatinine phosphokinase (CK) was 608
± 366 IU/l and CK-MB, 57.6±47.7 IU/l (normal values for CK and
CK-MB were 30–170 and 0–7 IU/l, respectively.) Mean creatinine
level was 2.09 ± 0.69 mg/dl. Out of 11 patients, 4 had typical
clinical and laboratory manifestation of scleroderma renal crisis on
admission. Out of 11 patients, 2 had new-onset atrial fibrillation,
and 4 out of 11 had electrocardiographic evidence of
intraventricular conduction abnormalities. On chest X-ray
evaluation 45.4% of patients had signs of congestive heart failure,
27.2% had pleural effusions, and 27.2% had interstitial lung fibrosis
changes. Initial blood pressure was 134 ± 17.8/77 ± 12.4 mm Hg.
Five patients had clearly defined atherosclerotic changes by
cardiac catheterization or examination of autopsy specimens
(45.4%), whereas three (27.2%) patients had normal coronary
arteries. In three cases the atherosclerotic status could not be
clearly defined. Out of 11 patients, 9 developed non-Q wave MIs.
All three of the nonatherosclerosis patients displayed this pattern.
On two-dimensional (2-D) echocardiography upon admission to the
hospital, the nonatherosclerotic cases showed no wall motion
abnormalities but concentric left ventricular hypertrophy (LVH) as
compared to the patients with atherosclerotic heart disease who
had wall motion abnormalities but no LVH. Four patients died
during these admissions, two from infections and two from
cardiogenic shock. From three autopsies performed, two patients
had moderate coronary atherosclerosis. The autopsy of the third
patient did not show any atherosclerotic changes, but perivascular
fibrosis of the coronary vessels and a diffuse lymphocytic infiltrate
of the myocardium were observed (Figs. 1 and 2).
Using as a historical control a previous retrospective study of 23
patients who had normal coronary arteries on angiography out of a
total 2,100 acute MI admissions [7], we calculated a significantly
higher odds of having normal coronary arteries in patients with
systemic sclerosis and an acute myocardial infarct as compared to
a control population (OR 33.86, 95% CI 14.08–81.39).

Discussion
Acute MI is an uncommon complication of SSc. It has been
suggested that some cases of MI in these patients may be caused
by coronary vasospasm rather than by atherosclerotic coronary
disease [6]. Indeed, thallium perfusion studies have provided
strong evidence that perfusion defects are common in patients with
systemic sclerosis and can occur both at rest and in response to
cold pressor provocation [13–16]. Because there is no evidence of
an increased risk for coronary atherosclerosis in this disease, it is
most likely that endothelial dysfunction plays a central role in the
involvement of the coronary vessels. The pathogenesis of coronary
vessel alterations in systemic sclerosis has been hypothesized to
result in a combination of both the typical microvascular disease
often present in SSc and atherosclerotic disease. It has been
suggested that perivascular cellular infiltrates with activated T cells
are responsible for the production and secretion of cytokines such
as transforming growth factor (TGF)-P, which injure the endothelial
cells and cause an increased expression of major histocompatibility
complex (MHC) class I and II antigens as well as of the adhesion
ligand intracellular adhesion molecule-1. Chemoattraction of
fibroblasts into the vessel wall most likely under the influence of
locally secreted TGF-P and their subsequent transdifferentiation
into myofibroblasts capable of increased production of collagens
and other extracellular matrix proteins cause a reduction in the
coronary lumen and vasomotor instability. These changes in the
vessel wall lead to endothelial injury, with exposure of the
subendothelium causing subsequent platelet aggregation and
thrombus formation [1]. In autopsy studies extramural coronary
vessels are often normal, while smaller intramural vessels show
intimal proliferation and intravascular thrombosis [17–19].
Cardiac wall motion abnormalities on 2-D echocardiography were
surprisingly absent in all three patients who did not have
atherosclerotic coronary artery disease, although concentric LVH
was uniformly present. In contrast, in patients who had
atherosclerotic disease, there were pronounced myocardial motion
abnormalities without LVH. These observations suggest that
coronary ischemia related to coronary vasospasm may be
responsible for the occurrence of MI in patients with SSc.
In our case series, 64% of SSc patients who developed MI had a
creatinine level of more than 1.3 mg/dl, and four were in

scleroderma renal crisis. While this may be in line with early
investigators who suggested that cardiac involvement in SSc may
be a manifestation of disease in other organs such as the kidneys
and the lungs [20], and the heart is involved secondary to the
associated systemic and pulmonary hypertension, it may also
represent a similar pathogenic process which leads these patients
to both have coronary and peripheral vascular involvement.
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Table & Figures

Table 1 Demographics of 11 SSc patients with acute myocardial infarction
_____________________________________________________
Age (years)
64.4±7.9
Sex (%)
Female
54.50
Race (%)
White
81.80
African-American
18.20
Clinical subset of SSc (%)
Limited
63.60
Diffuse
36.40
SSc symptoms (%)
Gastrointestinal
91
Raynaud’s phenomenon
81.80
Renal involvement
64
TBS skin involvement
15.1±12.3
SSc Systemic sclerosis, TBS total body surface

Fig. 1 Perivascular hyperplasia with fibrous deposition in a small
coronary vessel without atheroma and with total lumen occlusion.

Fig. 2 Diffuse lymphocytic infiltrates of the myocardium

